Neuroradiologic correlates of clinical disability and progression in the X-Linked leukodystrophy Pelizaeus-Merzbacher disease

Journal of the Neurological Sciences

Volumn 335, Issue 1-2, 2013, Pages 75-81

  Laukka, Jeremy J ^a,c   Stanley, Jeffrey A ^a   Garbern, James Y ^a   Trepanier, Angela ^a   Hobson, Grace ^b   Lafleur, Tori ^a   Gow, Alexander ^a   Kamholz, John ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Clinical disability; Genetics; Magnetic resonance imaging; Pelizaeus Merzbacher disease; Proteolipid protein; White matter atrophy

Indexed keywords

PROTEOLIPID PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CAUDATE NUCLEUS; CHILD; CONTROLLED STUDY; CORPUS CALLOSUM; DISABILITY; DISABILITY SEVERITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE DUPLICATION; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEURORADIOLOGY; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PELIZAEUS MERZBACHER DISEASE; PHENOTYPE; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA SPLICING; SCHOOL CHILD; SCORING SYSTEM; VALIDATION STUDY; WHITE MATTER; X CHROMOSOMAL INHERITANCE;

CLINICAL DISABILITY; GENETICS; MAGNETIC RESONANCE IMAGING; PELIZAEUS-MERZBACHER DISEASE; PROTEOLIPID PROTEIN; WHITE MATTER ATROPHY;

ADOLESCENT; ADULT; BRAIN; CHILD; CHILD, PRESCHOOL; CORPUS CALLOSUM; DISABLED PERSONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; MALE; MIDDLE AGED; MUTATION; MYELIN PROTEOLIPID PROTEIN; NERVE FIBERS, MYELINATED; NERVOUS SYSTEM DISEASES; PELIZAEUS-MERZBACHER DISEASE; YOUNG ADULT;

EID: 84888137920     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.08.030     Document Type: Article

References (40)

1. L.D. Hudson, C. Puckett, J. Berndt, J. Chan, and S. Gencic Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder Proc Natl Acad Sci U S A 86 20 1989 8128 8131
2. M.E. Hodes, V.M. Pratt, and S.R. Dlouhy Genetics of Pelizaeus-Merzbacher disease Dev Neurosci 15 1993 383 394
3. I. Griffiths, M. Klugmann, T. Anderson, C. Thomson, D. Vouyiouklis, and K.A. Nave Current concepts of PLP and its role in the nervous system Microsc Res Tech 4 1998 344 358
4. J.Y. Garbern Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis Cell Mol Life Sci 64 2007 50 65
5. K.J. Woodward The molecular and cellular defects underlying Pelizaeus-Merzbacher disease Expert Rev Mol Med 10 2008 e14
6. O. Boespflug-Tanguy, G. Giraud, C. Mimault, V. Isabelle, and D.P. Dinh Heterogeneous rearrangements of the PLP genomic region in Pelizaeus-Merzbacher disease: genotype-phenotype correlation in 41 patients Am J Hum Genet 65 1597 [Program Nr]
7. E.A. Sistermans, R.F. de Coo, I.J. de Wijs, and B.A. van Oost Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease Neurology 50 1998 1749 1754
8. A. Gow, and R. Sharma The unfolded protein response in protein aggregating diseases Neuromolecular Med 4 2003 73 94
9. A. Gow, and R.A. Lazzarini A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease Nat Genet 13 1996 422 428
10. A. Gow, C.M. Southwood, and R.A. Lazzarini Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease J Cell Biol 140 1998 925 934
11. J.Y. Garbern, D.A. Yool, G.J. Moore, I.B. Wilds, M.W. Faulk, and M. Klugmann Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation Brain 125 2002 551 561
12. F. Cailloux, F. Gauthier-Barichard, C. Mimault, V. Isabelle, V. Courtois, and G. Giraud Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations Eur J Hum Genet 8 2000 837 845
13. M.S. van der Knaap Magnetic resonance in childhood white-matter disorders Dev Med Child Neurol 43 10 2001 705 712
14. B. Plecko, S. Stockler-Ipsiroglu, S. Gruber, V. Mlynarik, E. Moser, and J. Simbrunner Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype Neuropediatrics 34 2003 127 136
15. J. Takanashi, K. Sugita, Y. Tanabe, K. Nagasawa, K. Inoue, and H. Osaka MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication J Neuroradiol 20 1999 1822 1828
16. M.E. Steenweg, A. Vanderver, S. Blaser, A. Bizzi, T.J. de Koning, and G.M. Mancini Magnetic resonance imaging pattern recognition in hypomyelinating disorders Brain 133 2010 2971 2982
17. A. Nezu, S. Kimura, S. Takeshita, H. Osaka, K. Kimura, and K. Inoue An MRI and MRS study of Pelizaeus-Merzbacher disease Pediatr Neurol 18 1998 334 337
18. J. Takanashi, K. Sugita, H. Osaka, M. Ishii, and H. Niimi Proton MR spectroscopy in Pelizaeus-Merzbacher disease AJNR Am J Neuroradiol 18 1997 533 535
19. J. Takanashi, K. Inoue, M. Tomita, A. Kurihara, F. Morita, and H. Ikehira Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication Neurology 58 2002 237 241
20. J. Takanashi, S. Saito, I. Aoki, A.J. Barkovich, Y. Ito, and K. Inoue Increased N-acetylaspartate in model mouse of Pelizaeus-Merzbacher disease J Magn Reson Imaging 35 Feb 2012 418 425
21. C. Caon, M. Zvartau-Hind, W. Ching, R.P. Lisak, A.C. Tselis, and O.A. Khan Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis Neurology 60 2003 323 325
22. H. Butzkueven, S.C. Kolbe, D.J. Jolley, J.Y. Brown, M.J. Cook, and I.A. van der Mei Validation of linear cerebral atrophy markers in multiple sclerosis J Clin Neurosci 15 2008 130 137
23. R.A. Bermel, R. Bakshi, C. Tjoa, S.R. Puli, and L. Jacobs Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis Arch Neurol 59 2002 275 280
24. A.M. Brickman, L.S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, and M.S. Albert Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease Arch Neurol 65 2008 1202 1208
25. A.E. Mamere, L.A. Saraiva, A.L. Matos, A.A. Carneiro, and A.C. Santos Evaluation of delayed neuronal and axonal damage secondary to moderate and severe traumatic brain injury using quantitative MR imaging techniques AJNR Am J Neuroradiol 30 2009 947 952
26. J.M. Cedarbaum, and N. Stambler Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials J Neurol Sci 152 Suppl. 1 1997 S1 S9
27. F. Seitelberger Pelizaeus-Merzbacher disease P.J. Vinken, G.W. Bruyn, Handbook of clinical neurology 10 1970 North Holland Publishing Co. Amsterdam 150 220
28. F. Seitelberger Neuropathology and genetics of Pelizaeus-Merzbacher disease Brain Pathol 5 1995 267 273
29. F. Seitelberger, S. Urbanits, and K.-A. Nave Pelizaeus-Merzbacher disease H.W. Moser, Neurodystrophies and neurolipidoses Handbook of clinical neurology 22 (66) 1996 Elsevier Science Amsterdam 559 579
30. A.A. Sima, C.R. Pierson, R.L. Woltjer, G.M. Hobson, J.A. Golden, and W.J. Kupsky Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1 Acta Neuropathol 118 2009 531 539
31. E.J. Arroyo, and S.S. Scherer On the molecular architecture of myelinated fibers Histochem Cell Biol 113 2000 1 18
32. N. Baumann, and D. Pham-Dinh Biology of oligodendrocyte and myelin in the mammalian central nervous system Physiol Rev 81 2001 871 927
33. J.M. Edgar, M. McLaughlin, M. McCulloch, J.A. Barrie, S.C. Zhang, and I.D. Duncan Axonal pathology in proteolipid protein deficient mice J Neurochem 85 2003 97
34. C.L. Tatar, S. Appikatla, D.A. Bessert, A.S. Paintlia, I. Singh, and R.P. Skoff Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain ASN Neuro 2 2010 e00043
35. I.D. Duncan The PLP mutants from mouse to man J Neurol Sci 228 15 2005 204 205
36. I.D. Duncan, J.P. Hammang, S. Goda, and R.H. Quarles Myelination in the jimpy mouse in the absence of proteolipid protein Glia 2 1989 148 154
37. L.A. Harsan, P. Poulet, B. Guignard, N. Parizel, R.P. Skoff, and M.S. Ghandour Astrocytic hypertrophy in dysmyelination influences the diffusion anisotropy of white matter J Neurosci Res 85 2007 935 944
38. I. Griffiths, M. Klugmann, T. Anderson, D. Yool, C. Thomson, and M.H. Schwab Axonal swellings and degeneration in mice lacking the major proteolipid of myelin Science 280 1998 1610 1613
39. J. Boulloche, and J. Aicardi Pelizaeus-Merzbacher disease: clinical and nosological study J Child Neurol 1 1986 233 239
40. W. Zeman, W. DeMyer, and H.F. Falls Pelizaeus-Merzbacher disease: a study in nosology J Neuropathol Exp Neurol 23 1964 334 354